Accell Group expects revenue for full year 2013 to be up compared to 2012 despite lower preseason sales and rampant product discounting at the end of the season. The Dutch company, parent of Raleigh, Currie Technologies, Seattle Bike ...
Do you know a woman who has made an impact in product engineering or design, led sales for a brand, managed a global sales company or advanced a major advocacy program? Nominate her to be included in BRAIN’s list of influential women ...
Tags: BRAIN, profile, influential, woman, February issue
U.S. scientists say they have developed a urine test for hard-to-detect blood clots, which can cause strokes and heart attacks. Lead author and doctoral candidate Kevin Lin, postdoctoral fellow Gabriel Kwong and Sangeeta N. Bhatia, all at ...
Oxytocin, the "bonding hormone" between mother and child, may also be the bonding hormone between husband and wife, researchers in Germany and China say. Dr. Rene Hurlemann, executive senior physician at the Inpatient and Outpatient ...
Tags: love, chemical, monogamous, couple
After 85 years, antibiotics are growing impotent. So what will medicine, agriculture and everyday life look like if we lose these drugs entirely? A few years ago, I started looking online to fill in chapters of my family history that no ...
Tags: imagining, post-antibiotics, future
Otsuka Pharmaceutical and H. Lundbeck have announced marketing authorization approval from the European Commission for Abilify Maintena (aripiprazole), an intramuscular (IM) once-monthly injectable formulation for maintenance treatment of ...
The Direxion Torqueable Microcatheter-a microcatheter for shrinking tumors or blocking aneurysms-has won FDA and CE Mark approval, Boston Scientific recently announced. The FDA granted the Direxion a 510(k) clearance because it retains ...
Tags: Boston Scientific Microcatheter, FDA Approval, Direxion a 510(k)
The RNS device receiced FDA approval via the PMA pathway. NeuroPace (Mountain View, CA) landed FDA PMA approval for its RNS Stimulator, a device that can detect and treat patients suffering from drug-resistant epilepsy. Seizures occur ...
Tags: RNS, FDA approval, PMA pathway, NeuroPace
For many suffering from blindness, the perfect Christmas gift has arrived. Next month, the Argus II Retinal Prothesis System by Second Sight is slated to go on sale in the United States. The Argus II by Second Sight can restore sight for ...
Tags: Bionic Eye, blindness
Researchers from the University of Adelaide are trying their best to find out the ways to exploit nanoparticles and their interactions with light. A 1,700-year-old Roman glass cup has opened a gate for researchers, which they believe would ...
Tags: Nanoparticles Properties, Glass
The four partners BRAIN, the Hohenstein Institute, Kelheim Fibres and rkona, announce the formation of a new research alliance for the biotechnical production and modification of specialty alginates. The aim of the alliance is to establish ...
Tags: alliance, Microbial, production, application, biopolymer
US-based Boston Scientific has obtained CE Mark approval for its Vercise deep brain stimulation (DBS) system for the treatment of intractable primary and secondary dystonia. Dystonia is a neurological movement disorder characterized by ...
Tags: Dystonia Treatment, DBS System
Qualcomm wants to make tablets and smartphones more perceptive by giving the devices a “silicon brain,” company CEO Paul Jacobs said Wednesday. The company wants to load mobile devices with its Zeroth processor, which is ...
Tags: Qualcomm, Mobile Devices, 'brains'
The US Food and Drug Administration (FDA) has accepted AstraZeneca's new drug application (NDA) for naloxegol, an investigational peripherally-acting mu-opioid receptor antagonist (PAMORA). The drug has been studied in opioid-induced ...
Tags: Drug Application, FDA Approval
Particle Sciences, a drug delivery contract development and manufacturing organization, has been contracted by BHR Pharma to develop an in-field nasally applied formulation of progesterone for traumatic brain injury (TBI). BHR Pharma is ...